Arg972 Insulin receptor substrate-1 is associated with decreased serum angiotensin-converting enzyme 2 levels in acute myocardial infarction patients: In vivo and in vitro evidence

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Liu, Wei ^a   Zhou, Xinmin ^b   Yu, Fenglei ^b   Hu, Jianguo ^b   Hu, Wen ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Acute myocardial infarction; Angiotensin converting enzyme 2; Gene polymorphism; Insulin receptor substrate 1

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ARGININE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; DIPEPTIDYL CARBOXYPEPTIDASE; INSULIN RECEPTOR SUBSTRATE; IRS1 PROTEIN, HUMAN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; ANOXIA; CASE CONTROL STUDY; CELL CULTURE; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HEART INFARCTION; HEART MUSCLE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ANOXIA; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; PEPTIDYL-DIPEPTIDASE A; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RENIN-ANGIOTENSIN SYSTEM; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

EID: 84885486383     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-151     Document Type: Article

References (27)

1. Burchill LJ, Velkoska E, Dean RG, Griggs K, Patel SK, Burrell LM. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions. Clin Sci (Lond) 2012, 123:649-658. 10.1042/CS20120162, 22715807.
2. Mazzolai L, Pedrazzini T, Nicoud F, Gabbiani G, Brunner HR, Nussberger J. Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normotensives mice. Hypertension 2000, 35:985-991. 10.1161/01.HYP.35.4.985, 10775573.
3. Raizada MK, Ferreira AJ. ACE2: a new target for cardiovascular disease therapeutics. J Cardiovasc Pharmacol 2007, 50:112-119. 10.1097/FJC.0b013e3180986219, 17703127.
4. Burrell LM, Risvanis J, Kubota E, Dean RG, MacDonald PS, Lu S, Tikellis C, Grant SL, Lew RA, Smith AI, Cooper ME, Johnston CI. Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J 2005, 114:1-7.
5. Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD, Timens W, Turner AJ, Navis G, van Goor H. The emerging role of ACE2 in physiology and disease. J Pathol 2007, 212:1-11. 10.1002/path.2162, 17464936.
6. Der Sarkissian S, Grobe JL, Yuan L, Narielwala DR, Walter GA, Katovich MJ, Raizada MK. Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology. Hypertension 2008, 51:712-718. 10.1161/HYPERTENSIONAHA.107.100693, 18250366.
7. Zhao Y, Yin HQ, Yu QT, Qiao Y, Dai HY, Zhang MX, Zhang L, Liu YF, Wang LC, Liu de S, Deng BP, Zhang YH, Pan CM, Song HD, Qu X, Jiang H, Liu CX, Lu XT, Liu B, Gao F, Dong B. ACE2 overexpression ameliorates left ventricular remodeling and function in rats with myocardial infarction. Hum Gene Ther 2010, 21:1545-1554. 10.1089/hum.2009.160, 20507236.
8. Perez JTO, Riera M, Genover XB, De Caralt TM, Perea RJ. Serum ACE2 activity correlates with infarct size and left ventricular dysfunction during acute myocardial infarction. J Cardiovas Magn Res 2011, 13(Suppl 1):142.
9. Nagoshi T, Matsui T, Aoyama T, Leri A, Anversa P, Li L, Ogawa W, del Monte F, Gwathmey JK, Grazette L, Hemmings BA, Kass DA, Champion HC, Rosenzweig A. PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest 2005, 115:2128-2138. 10.1172/JCI23073, 1172227, 16007268.
10. King KL, Opie LH. Glucose and glycogen utilization in myocardial ischemia-changes in metabolism and consequences for the myocyte. Mol Cell Biochem 1998, 180:3-26. 10.1023/A:1006870419309, 9546626.
11. Apstein CS, Opie LH. Glucose-insulin-potassium (GIK) for acute myocardial infarction: a negative study with a positive value. Cardiovasc Drugs Ther 1999, 13:185-189. 10.1023/A:1007757407246, 10439880.
12. Maarman G, Marais E, Lochner A, du Toit EF. Effect of chronic CPT-1 inhibition on myocardial ischemia-reperfusion injury (I/R) in a model of diet-induced obesity. Cardiovasc Drugs Ther 2012, 26:205-216. 10.1007/s10557-012-6377-1, 22407171.
13. Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H, Quon MJ. Roles for insulin receptor, PI3-kinase, and Akt in insulin signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000, 101:1539-1545. 10.1161/01.CIR.101.13.1539, 10747347.
14. Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ, King GL. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000, 101:676-681. 10.1161/01.CIR.101.6.676, 10673261.
15. Fallucca F, Dalfrà MG, Sciullo E, Masin M, Buongiorno AM, Napoli A, Fedele D, Lapolla A. Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy. Metabolism 2006, 55:1451-1456. 10.1016/j.metabol.2006.06.004, 17046546.
16. Huang C, Lin Z, Zhou Y, Fang M, Sun S, Jiang W, Dong H, Lv B, Lan H, Chen M, Yang T, Zeng H, Chen J. Arg(972) insulin receptor substrate-1 is associated with elevated plasma endothelin-1 level in hypertensives. J Hypertens 2012, 30:1751-1757. 10.1097/HJH.0b013e3283561400, 22759779.
17. Federici M, Petrone A, Porzio O, Bizzarri C, Lauro D, DAlfonso R, Patera I, Cappa M, Nisticò L, Baroni M, Sesti G, di Mario U, Lauro R, Buzzetti R. The Gly972→Arg IRS-1 variant is associated with type 1 diabetes in continental Italy. Diabetes 2003, 52:887-890. 10.2337/diabetes.52.3.887, 12606535.
18. Yang W, Huang W, Su S, Li B, Zhao W, Chen S, Gu D. Association study of ACE2 (angiotensin I-converting enzyme 2) gene polymorphisms with coronary heart disease and myocardial infarction in a Chinese Han population. Clin Sci (Lond) 2006, 111:333-340. 10.1042/CS20060020, 16822235.
19. Myerson M, Coady S, Taylor H, Rosamond WD, Goff DC. Declining severity of myocardial infarction from 1987 to 2002: the atherosclerosis risk in communities (ARIC) study. Circulation 2009, 119:503-514. 10.1161/CIRCULATIONAHA.107.693879, 19153274.
20. Porzio O, Federici M, Hribal ML, Lauro D, Accili D, Lauro R, Borboni P, Sesti G. The Gly972->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. J Clin Invest 1999, 104:357-364. 10.1172/JCI5870, 408413, 10430617.
21. Holmquist L, Jögi A, Pa° hlman S. Phenotypic persistence after reoxygenation of hypoxic neuroblastoma cells. Int J Cancer 2005, 116:218-225. 10.1002/ijc.21024, 15800931.
22. Matsui T, Li L, del Monte F, Fukui Y, Franke TF, Hajjar RJ, Rosenzweig A. Adenoviral gene transfer of activated PI 3-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 1999, 100:2373-2379. 10.1161/01.CIR.100.23.2373, 10587343.
23. Lambert DW, Yarski M, Warner FJ, Thornhill P, Parkin ET, Smith AI, Hooper NM, Turner AJ. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J Biol Chem 2005, 280:30113-30119. 10.1074/jbc.M505111200, 15983030.
24. Rzymski T, Petry A, Kračun D, Rieß F, Pike L, Harris AL, Görlach A. The unfolded protein response controls induction and activation of ADAM17/TACE by severe hypoxia and ER stress. Oncogene 2012, 31:3621-3634. 10.1038/onc.2011.522, 22105359.
25. Handley MG, Medina RA, Nagel E, Blower PJ, Southworth R. PET imaging of cardiac hypoxia: opportunities and challenges. J Mol Cell Cardiol 2011, 51:640-650. 10.1016/j.yjmcc.2011.07.005, 3408239, 21781973.
26. Povel CM, Boer JM, Onland-Moret NC, Dollé ME, Feskens EJ, van der Schouw YT. Single nucleotide polymorphisms (SNPs) involved in insulin resistance, weight regulation, lipid metabolism and inflammation in relation to metabolic syndrome: an epidemiological study. Cardiovasc Diabetol 2012, 11:133. 10.1186/1475-2840-11-133, 3507796, 23101478.
27. Underwood PC, Adler GK. The renin angiotensin aldosterone system and insulin resistance in humans. Curr Hypertens Rep 2013, 15:59-70. 10.1007/s11906-012-0323-2, 23242734.